FDA approved keytruda for use as adjuv... - Lung Cancer Support

Lung Cancer Support

3,999 members2,169 posts

FDA approved keytruda for use as adjuvant treatment for use by Stages 1B, 2, and 3A nsclc.

Denzie profile image
DenzieModeratorVolunteer
1 Reply

previously allocated only to stages 3B and 4. It has proved to extend the length of progression free survival in lower stages of nsclc.

fda.gov/drugs/resources-inf...

For the newbies among us, adjuvant therapy is a helper therapy given after main form of treatment is finished (example surgery).

Written by
Denzie profile image
Denzie
Moderator
To view profiles and participate in discussions please or .
Read more about...
1 Reply
JeanE41 profile image
JeanE41

Glad to see that they are expanding the use of these drugs. It gives me hope for longer survival.

You may also like...

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

release here:...

First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)

the full FDA press release:...

EGFR exon 19 mutation

six day cycles of chemotherapy and 30 radiation treatments in December and January, I opted for...

New here... Dad w/ IIb, 7 cm tumor - ISO tips prior to tmrt & surgery

clinically stage IIb adenocarcinoma NSCLC. At UCSF the drs. are recommending neoadjuvant therapy...

Time for some SBRT - and for keeping it real

of five SBRT (stereotactic body radiation therapy) treatments tomorrow aimed at the culprit hiding...